San Francisco-based Transcarent is a new consumer-directed health and care platform for employees of self-insured employers and their families. The company was created to improve the quality and value of care in America by providing a new health and care experience for employees and their families by providing greater control over their healthcare decisions and enabling them to share in the financial benefits of those decisions.

On March 18, 2021, Transcarent announced that Glen Tullman has added the role of CEO to his role of executive chairman of the company. In October 2020, Transcarent closed a $40 million Series A financing round led by General Catalyst (Hemant Taneja) and 7wire Ventures (Lee Shapiro), with participation from Alta Partners and Jove Equity Partners. In connection with the Series A financing, Transcarent also acquired BridgeHealth, the industry-leading provider of surgical advocacy and centers of excellence (COE) programs for large, self-insured organizations and their members. Transcarent and these transactions were recently profiled in this Forbes article.

Wilson Sonsini Goodrich & Rosati advised Transcarent on both the Series A financing and the acquisition of BridgeHealth. In addition, the firm previously represented Livongo—a company founded by Mr. Tullman—in its 2019 IPO, which was the largest consumer digital health IPO in history.

The Wilson Sonsini team that advised Transcarent on the Series A financing and associated acquisition of BridgeHealth includes:

Corporate
Mark Baudler
Jonathan Chan
Annie Giomi
Jon Loebl

M&A
Rich Mullen
Kenji Strait
Tracy Sevush

Technology Transactions
Christopher Paniewski

Employee Benefits and Compensation
Sriram Krishnamurthy
Matthew Norgard

Employment and Trade Secret Litigation
Aren Balabanian

Privacy and Cybersecurity
Matt Staples
Daniel Chen
Haley Bavasi

Real Estate
James McCann

Tax
Myra Sutanto Shen

Delaware Law
Ryan Greecher